{"id":5619,"date":"2017-12-29T06:36:05","date_gmt":"2017-12-29T06:36:05","guid":{"rendered":"https:\/\/www.quancapital.com\/?page_id=5619"},"modified":"2023-12-06T07:54:22","modified_gmt":"2023-12-06T07:54:22","slug":"home","status":"publish","type":"page","link":"https:\/\/cn.quancapital.com\/en\/","title":{"rendered":"Home"},"content":{"rendered":"<p>[vc_row content_width=&#8221;grid&#8221; css=&#8221;.vc_custom_1516094357929{padding-top: 90px !important;padding-bottom: 90px !important;}&#8221;][vc_column]<div class=\"qodef-blog-list-holder qodef-image-in-box \">\r\n\t<ul class=\"qodef-blog-list\">\r\n\t<li class=\"qodef-blog-list-item clearfix\">\r\n\t<div class=\"qodef-blog-list-item-inner\">\r\n\t\t<div class=\"qodef-item-image clearfix\">\r\n\t\t\t<a href=\"https:\/\/cn.quancapital.com\/wp-content\/uploads\/2026\/04\/20260414-Tempest-Appoints-Andrew-Fang-Ph.D.-as-Head-of-Business-Development-to-Advance-Strategic-Partnerships-and-Global-Licensing-Efforts.pdf#new_tab\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t<\/a>\r\n\t\t<\/div>\r\n\t\t<div class=\"qodef-item-text-holder\">\t\t\t\r\n\t\t\t<h4 class=\"qodef-item-title \">\r\n\t\t\t\t<a href=\"https:\/\/cn.quancapital.com\/wp-content\/uploads\/2026\/04\/20260414-Tempest-Appoints-Andrew-Fang-Ph.D.-as-Head-of-Business-Development-to-Advance-Strategic-Partnerships-and-Global-Licensing-Efforts.pdf#new_tab\" >\r\n\t\t\t\t\tTempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts\t\t\t\t<\/a>\r\n\t\t\t<\/h4>\r\n\r\n\t\t\t\t\t\t\t<p class=\"qodef-excerpt\">...<\/p>\r\n\t\t\t\t\t\t<div class=\"qodef-item-info-section\">\r\n\t\t\t\t<div class=\"qodef-post-info-date\">\r\n\t\r\n\t\tApril 14, 2026\r\n\t\t<\/div>\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\t\r\n<\/li>\r\n<li class=\"qodef-blog-list-item clearfix\">\r\n\t<div class=\"qodef-blog-list-item-inner\">\r\n\t\t<div class=\"qodef-item-image clearfix\">\r\n\t\t\t<a href=\"https:\/\/cn.quancapital.com\/wp-content\/uploads\/2026\/04\/20260410-Oricell-Therapeutics-Closes-110-Million-Pre-IPO-Financing-to-Accelerate-Global-Development-of-Solid-Tumor-CAR-T-Therapies.pdf#new_tab\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t<\/a>\r\n\t\t<\/div>\r\n\t\t<div class=\"qodef-item-text-holder\">\t\t\t\r\n\t\t\t<h4 class=\"qodef-item-title \">\r\n\t\t\t\t<a href=\"https:\/\/cn.quancapital.com\/wp-content\/uploads\/2026\/04\/20260410-Oricell-Therapeutics-Closes-110-Million-Pre-IPO-Financing-to-Accelerate-Global-Development-of-Solid-Tumor-CAR-T-Therapies.pdf#new_tab\" >\r\n\t\t\t\t\tOricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies\t\t\t\t<\/a>\r\n\t\t\t<\/h4>\r\n\r\n\t\t\t\t\t\t\t<p class=\"qodef-excerpt\">...<\/p>\r\n\t\t\t\t\t\t<div class=\"qodef-item-info-section\">\r\n\t\t\t\t<div class=\"qodef-post-info-date\">\r\n\t\r\n\t\tApril 10, 2026\r\n\t\t<\/div>\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\t\r\n<\/li>\r\n<li class=\"qodef-blog-list-item clearfix\">\r\n\t<div class=\"qodef-blog-list-item-inner\">\r\n\t\t<div class=\"qodef-item-image clearfix\">\r\n\t\t\t<a href=\"https:\/\/cn.quancapital.com\/wp-content\/uploads\/2026\/04\/20260407-NextCure-Receives-Fast-Track-Designation-for-SIM0505-CDH6-ADC-in-Ovarian-Cancer.pdf#new_tab\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t<\/a>\r\n\t\t<\/div>\r\n\t\t<div class=\"qodef-item-text-holder\">\t\t\t\r\n\t\t\t<h4 class=\"qodef-item-title \">\r\n\t\t\t\t<a href=\"https:\/\/cn.quancapital.com\/wp-content\/uploads\/2026\/04\/20260407-NextCure-Receives-Fast-Track-Designation-for-SIM0505-CDH6-ADC-in-Ovarian-Cancer.pdf#new_tab\" >\r\n\t\t\t\t\tNextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer\t\t\t\t<\/a>\r\n\t\t\t<\/h4>\r\n\r\n\t\t\t\t\t\t\t<p class=\"qodef-excerpt\">...<\/p>\r\n\t\t\t\t\t\t<div class=\"qodef-item-info-section\">\r\n\t\t\t\t<div class=\"qodef-post-info-date\">\r\n\t\r\n\t\tApril 7, 2026\r\n\t\t<\/div>\t\t\t<\/div>\r\n\t\t<\/div>\r\n\t<\/div>\t\r\n<\/li>\r\n\t<\/ul>\t\r\n<\/div>\r\n<a href=\"https:\/\/cn.quancapital.com\/news\" target=\"_self\" style=\"margin: auto\" class=\"qodef-btn qodef-btn-medium qodef-btn-default news-button qodef-btn-hover-animation\"  >\n            <span    class=\"qodef-animation-overlay\"><\/span>\n        <span class=\"qodef-btn-text\">All news<\/span>\n    <span class=\"qodef-btn-text-icon\"><\/span>\n<\/a>[\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row content_width=&#8221;grid&#8221; css=&#8221;.vc_custom_1516094357929{padding-top: 90px !important;padding-bottom: 90px !important;}&#8221;][vc_column][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full-width.php","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/pages\/5619"}],"collection":[{"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/comments?post=5619"}],"version-history":[{"count":5,"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/pages\/5619\/revisions"}],"predecessor-version":[{"id":6878,"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/pages\/5619\/revisions\/6878"}],"wp:attachment":[{"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/media?parent=5619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}